Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Paradigm Genetics Sacks CEO, President Ryals

NEW YORK, Feb. 27 - Paradigm Genetics has fired its CEO and President John A. Ryals and has appointed Chief Scientific Officer John E. Hamer to take the helm while a "global search is conducted.

Ryals founded the company in 1997 and has since served as CEO and president.

Hamer, who received his PhD in microbiology from the University of California, Davis, came to Paradigm from Purdue University where he was an adjunct professor of microbiology and immunology.

Paradigm did not offer a reason for Ryals' sudden dismissal. But in an interview, Melissa Matson, a company spokeswoman, said that the dismissal capped "a period over a course of time of some dysfunction in the relationship between him and the board and him and the management team."

"It really was not one single event" that led to his dismissal, she added.

The decision was made by the board of directors, which met on Monday and Tuesday, according to sources in the company. Matson confirmed that the board made its decision in a meeting on Tuesday but stressed that the meeting was planned ahead of time to talk about "strategy and our new budget for the year."


"Evidently on Monday night [the board] came to the conclusion that it [would be] probably better for the company and for the shareholders to part ways with John," Matson told GenomeWeb on Wednesday. "It was shocking."


Shares of the Research Triangle Park, NC-based company were down $.20, or more than 11 percent, at $1.50 in late-morning Nasdaq trading. The stock has falling regularly from a 52-week high of $9.10, reached in late December.


"It was a surprise to us in the sense of the timing," said Christopher Meldrum, director of corporate alliances at Paradigm.


Ian Mehr, director of business development, at Paradigm, agreed with his colleague but added that the change "signals a good move for the company. John Ryals thought of innovative ways to conduct functional genomics. But like [most] entrepreneurial companies, management changes are necessary."


Mehr said Ryals was one of four company founders, and the last to have been with the company.


The company employs roughly 250 employees, according to Mehr. Paradigm plans to hold a company-wide meeting to discuss the changes, he added.


Ken Howard, in Santa Clara, Calif., contributed to this report.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.